One of the most challenging exercises during risk management of a medical device is the evaluation of overall residual risk relative to the benefits of its intended use.
➡️This is because there is no cookie-cutter formula and this evaluation generally involves a lot of (clinical) judgment.
➡️When it comes to benefit-risk assessment of an AI/ML enabled dev…
Listen to this episode with a 7-day free trial
Subscribe to Let's Talk Risk! to listen to this post and get 7 days of free access to the full post archives.
